Clinical Trial Update: Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated concomitant administration of Menactra with a fifth dose of DAPTACEL in children aged 4 to 6 years. The study has completed, and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Meningococcal Meningitis
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• DAPTACEL (Diphtheria Tetanus Acellular Pertussis Vaccine Adsorbed)
• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))

Snippet

Sponsor: Sanofi | Conditions: Meningococcal Meningitis, Tetanus | Phase 2 | Status: COMPLETED | Results posted: 2011-08-23